SCHEMBL30429353

SCHEMBL30429353

CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(=O)O)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ RAMP3 O60896 9/20 0.56
▸ CALCR P30988 9/20 0.56
▸ NPY2R P49146 7/20 0.54
▸ NPY4R P50391 7/20 0.54
▸ NPY5R Q15761 7/20 0.54
▸ NPY1R P25929 5/20 0.54
▸ CXCR4 P61073 1/20 0.52
▸ MAPK8 P45983 1/20 0.51
▸ MAPK9 P45984 1/20 0.51
▸ MAPK10 P53779 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29680080 0.99 RAMP3 (0.56) RAMP3CALCRNPY2RNPY4RNPY5R
SCHEMBL29680011 0.98 RAMP3 (0.56) RAMP3CALCRNPY2RNPY4RNPY5R
SCHEMBL29679504 0.96 RAMP3 (0.57) RAMP3CALCRNPY2RNPY4RNPY5R
SCHEMBL29679604 0.96 RAMP3 (0.57) RAMP3CALCRNPY2RNPY4RNPY5R
SCHEMBL30431765 0.92 NPY2R (0.60) RAMP3CALCRNPY2RNPY4RNPY5R
SCHEMBL30974402 0.90 NPY2R (0.55) RAMP3CALCRNPY2RNPY4RNPY5R
SCHEMBL30512553 0.90 KDM1A (0.56) RAMP3CALCRNPY2RNPY4RNPY5R
SCHEMBL30009114 0.89 NPY2R (0.54) RAMP3CALCRNPY2RNPY4RNPY5R
SCHEMBL29377791 0.89 RAMP3 (0.56) RAMP3CALCRNPY2RNPY4RNPY5R
SCHEMBL31416061 0.89 RAMP3 (0.51) RAMP3CALCRNPY2RNPY4RNPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230165951-A1 Engineering, production and characterization of plant produced Nucleocapsid and Spike structural proteins of SARS CoV 2 as vaccine candidates against COVID19 MAMEDOV TARLAN (TR) 2023-06-01 — — US disclosed
Send feedback